@JackCurryYES why not give The Martian some big league at Bats instead of Grichuk? Grichuk at bats have been anemic. Invest in Jasson instead. Dont get it
@elonmusk I love my FSD also, but in the past month it almost ran through 2 school buses stopped with lights on and it constantly tries to turn right on “no turn on red” intersections. Will it learn?
$vktx too late to the GLP1 game, pricing pressure and high cogs results in low margins, differentiation is minimal when so late to the game…need big pharma to compete commercially and they all passed. Game over in weight loss. MASH has potential.
@Pharmdca Pricing and reimbursement dynamics have cratered and will only get worse when LLY and NOVO drugs negotiate with CMS, then MFN risk. VKTX missed the window.